ICU MEDICAL INC/DE

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Total Revenue $379.4m
$1.3b +240.72%
$1.4b +8.31%
$1.3b -9.56%
$1.3b +0.38%
$1.3b +3.56%
$2.3b +73.21%
$2.3b -0.92%
$2.4b +5.44%
$2.2b -6.33%
$2.2b -3.21%
Cost of Revenue $178.0m
$866.5m +386.88%
$830.0m -4.21%
$794.3m -4.30%
$809.5m +1.91%
$824.8m +1.89%
$1.6b +91.83%
$1.5b -3.98%
$1.6b +2.50%
$1.4b -9.51%
$1.3b -6.72%
Gross Profit $201.4m
$426.1m +111.57%
$570.0m +33.78%
$471.9m -17.22%
$461.5m -2.20%
$491.5m +6.50%
$697.8m +41.97%
$739.9m +6.04%
$824.8m +11.48%
$822.0m -0.33%
$845.1m +2.81%
Interest Income (Expense), Net ($66.4m)
($95.2m) -43.46%
($95.8m) -0.56%
($83.0m) +13.29%
$9.4m +111.33%
Research and Development Expense $13.0m $51.3m $52.9m $48.6m $42.9m $47.5m $93.0m $85.3m $88.6m $87.5m $86.3m
Selling, General and Administrative Expense $89.4m $304.0m $328.1m $277.0m $284.0m $302.6m $608.3m $606.7m $638.8m $625.2m $615.1m
Amortization of Intangible Assets $2.8m $15.0m $16.6m $17.7m $23.2m $23.8m $139.4m $132.1m $134.3m $131.4m
Restructuring and Related Cost, Incurred Cost $19.6m $30.0m
Restructuring Costs $774k $18.8m $4.5m $8.4m $7.9m $140k $9.7m $6.7m $19.6m $30.0m
Operating Expenses $118.5m $441.2m $548.4m $364.5m $363.3m $368.2m $740.7m $717.0m $781.8m $779.2m $701.4m
Operating Income (Loss) $82.9m
($15.1m) -118.18%
$21.6m +243.33%
$107.4m +396.76%
$98.2m -8.57%
$123.2m +25.55%
($42.9m) -134.81%
$22.8m +153.21%
$43.0m +88.23%
$42.8m -0.31%
$143.8m +235.64%
Other Operating Income (Expense), Net $82.9m $15.1m $21.6m $107.4m $98.2m $123.2m ($5.1m) ($5.9m) ($13.2m) ($232k)
Interest Expense $2.0m $709k $549k $1.8m $858k $70.8m $102.7m $106.5m $93.3m $82.1m
Interest Expense, Debt $75.0m $133.9m $133.3m $104.1m $82.1m
Interest Income, Other $4.4m $7.5m $10.8m $10.3m $9.4m
Foreign Currency Transaction Gain (Loss), Realized $300k ($1.8m) ($7.9m) $700k ($7.2m) ($1.0m) ($5.8m) ($5.9m) ($9.8m) $3.8m
Income (Loss) from Equity Method Investments $0 $0 ($1.2m)
Interest Income (Expense), Nonoperating, Net ($66.4m) ($95.2m) ($95.8m) ($83.0m) $9.4m
Income (Loss) from Continuing Operations before Income Taxes, Domestic $80.7m $59.9m ($8.6m) $32.8m $41.2m $81.5m ($135.6m) ($137.0m) ($116.0m) ($31.5m) $754k
Current Income Tax Expense (Benefit) $24.6m $8.2m $11.5m $17.4m $15.7m $31.3m $20.9m $22.8m $46.0m $16.2m ($31.0m)
Income Tax Expense (Benefit) $22.1m ($17.4m) ($6.4m) $13.7m $10.6m $20.1m ($40.1m) ($48.6m) $51.7m $2.4m ($31.0m)
Net Income (Loss) Attributable to Parent $63.1m
$68.6m +8.81%
$28.8m -58.05%
$101.0m +250.90%
$86.9m -14.02%
$103.1m +18.72%
($74.3m) -172.03%
($29.7m) +60.08%
($117.7m) -296.86%
$732k +100.62%
$30.1m +4010.52%
Earnings Per Share, Basic $3.90 $3.50 $1.41 $4.90 $4.16 $4.86 ($3.11) ($1.23) ($4.83) $0.03 $1.20
Earnings Per Share, Diluted $3.66 $3.29 $1.33 $4.69 $4.02 $4.74 ($3.11) ($1.23) ($4.83) $0.03 $1.19
Weighted Average Number of Shares Outstanding, Basic 16.2m 19.6m 20.4m 20.6m 20.9m 21.2m 23.9m 24.1m 24.4m 24.6m 24.8m
Weighted Average Number of Shares Outstanding, Diluted 17.3m 20.9m 21.6m 21.5m 21.6m 21.8m 23.9m 24.1m 24.4m 24.9m 25.1m
Additional Financial Items
Goodwill, Impairment Loss $0
Income (Loss) Attributable to Parent, before Tax $123.2m ($114.4m) ($78.3m) ($66.0m) $4.4m
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent $85.2m $51.3m $22.4m $114.7m $97.5m $78.3m $66.0m $4.4m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.